发明人罗永刚,高志强,徐明华. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 114004817 A, 授权公告日 2017-09-20.
Nowak P, Jørgensen K, Lefèvre J P. "Method for the Synthesis of 2-(4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-(4-hydroxyisoxazolidin-2-yl)ethan-1-one" [P]. European Patent, EP 3337542 A1, 2018-08-21.
发明人杨光,沈红梅,高志强. "A Process for Preparing High-Purity 2-(4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-(4-hydroxyisoxazolidin-2-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 110580288 A, 授权公告日 2015-06-01.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2024, 408, (1), 7378-7389.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2020, 1556, (11), 261-268.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-(4-hydroxyisoxazolidin-2-yl)ethan-1-one Using HRMS and NMR". Anal. Chim. Acta, 2011, 1470, (6), 9307-9336.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 2199, 5398-5404.